National Research Corp Stock Alpha and Beta Analysis
| NRC Stock | USD 19.64 0.52 2.72% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as National Research Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in National Research over a specified time horizon. Remember, high National Research's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to National Research's market risk premium analysis include:
Beta 1.83 | Alpha (0.31) | Risk 2.61 | Sharpe Ratio (0.05) | Expected Return (0.14) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
National |
National Research Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. National Research market risk premium is the additional return an investor will receive from holding National Research long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in National Research. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate National Research's performance over market.| α | -0.31 | β | 1.83 |
National Research expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of National Research's Buy-and-hold return. Our buy-and-hold chart shows how National Research performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.National Research Market Price Analysis
Market price analysis indicators help investors to evaluate how National Research stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading National Research shares will generate the highest return on investment. By understating and applying National Research stock market price indicators, traders can identify National Research position entry and exit signals to maximize returns.
National Research Return and Market Media
The median price of National Research for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 20.26 with a coefficient of variation of 7.32. The daily time series for the period is distributed with a sample standard deviation of 1.49, arithmetic mean of 20.33, and mean deviation of 1.34. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Karas Kevin R of 10981 shares of National Research subject to Rule 16b-3 | 09/11/2024 |
2 | Natura Resources Molten Salt Reactor at ACU Receives Historic NRC Construction Permit | 09/16/2024 |
3 | Rare Element Resources gets DOE nod for Wyomingrare earth demo plant | 09/27/2024 |
4 | Supreme Court grants Biden administration request to hear nuclear fuel storage case | 10/04/2024 |
5 | Disposition of 4600 shares by Amandla Mk Trust of National Research at 41.2211 subject to Rule 16b-3 | 10/09/2024 |
| National Research dividend paid on 11th of October 2024 | 10/11/2024 |
6 | National Research Co. Shares Bought by QV Investors Inc. | 10/16/2024 |
7 | US NRC Awards Oberon Technologies Extended Reality for Technical Training Contract | 10/23/2024 |
8 | National Research GAAP EPS of 0.24, revenue of 35.8M | 10/25/2024 |
9 | National Research Has Announced A Dividend Of 0.12 - Yahoo Finance | 10/31/2024 |
10 | National Research Third Quarter 2024 Earnings EPS US0.24 | 11/12/2024 |
11 | Kayne Anderson Rudnick Investment Management LLC Increases Stake in National Research Corp | 11/14/2024 |
12 | Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health | 11/20/2024 |
About National Research Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including National or other stocks. Alpha measures the amount that position in National Research Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.008677 | 0.0225 | 0.0375 | 0.0305 | Price To Sales Ratio | 7.13 | 6.13 | 6.53 | 9.85 |
National Research Upcoming Company Events
As portrayed in its financial statements, the presentation of National Research's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National Research's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of National Research's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of National Research. Please utilize our Beneish M Score to check the likelihood of National Research's management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with National Research
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out National Research Backtesting, National Research Valuation, National Research Correlation, National Research Hype Analysis, National Research Volatility, National Research History and analyze National Research Performance. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
National Research technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.